Abridge vs Nabla
Side-by-side comparison of Abridge and Nabla: pricing, features, API access, and community ratings.
Abridge is the enterprise leader with deeper specialty coverage (40+), multilingual support (28 languages), and advanced hallucination prevention technology, making it ideal for large health systems requiring maximum accuracy and scale. Nabla offers a more accessible entry point with a free tier and focuses on rapid documentation time reduction, making it better suited for smaller practices or individual clinicians testing ambient AI. Both integrate with major EHRs, but Abridge's proven deployment at elite systems like Mayo Clinic suggests more robust enterprise support, while Nabla's 100,000+ active users and freemium model indicates stronger grassroots adoption.
Abridge Generative AI for clinical conversations — turning patient encounters into accurate documentation | Nabla Ambient AI for clinicians — automated medical documentation, dictation, and real-time clinical intelligence | |
|---|---|---|
| Category | Healthcare & biotech | Healthcare & biotech |
| Pricing | Enterprise | Freemium |
| Starting price | ||
| Free tier | ||
| Audience | All audiences | All audiences |
| API available | ||
| Open source | ||
| Self-hostable | ||
| Model provider | OpenAI (GPT-5.5 and frontier models referenced) | |
| Founded | 2018 | 2018 |
| Headquarters | Pittsburgh, USA | New York, USA |
| Key strengths |
|
|